UNITUXIN
Live / Registered — Registered and renewed (as of 02 Feb 2026)
What this means for you
Registered since 10 Nov 2015. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 10 Nov 2025).
Record
- Serial number
- 85958337
- Registration number
- 4851651
- Mark type
- Stylized text
- Filed
- 12 Jun 2013
- Published for opposition
- 05 Nov 2013
- Registered
- 10 Nov 2015
- Next maintenance due
- 10 Nov 2025
- Attorney of record
- Norm J. Rich
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer; tumor suppressing agents
Owner
- United Therapeutics Corporation, Silver Spring, MD, US
- United Therapeutics Corporation, Silver Spring, MD, US
- United Therapeutics Corporation, Silver Spring, MD, US
Prosecution history
- 02 Feb 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 02 Feb 2026 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 02 Feb 2026 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 02 Feb 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Oct 2025 — TEAS SECTION 8 & 9 RECEIVED
- 10 Nov 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 17 Dec 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 17 Dec 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 17 Dec 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Sept 2021 — TEAS SECTION 8 & 15 RECEIVED
- 10 Nov 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 10 Nov 2015 — REGISTERED-PRINCIPAL REGISTER
- 07 Oct 2015 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Oct 2015 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Sept 2015 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED